Larvol Delta - Posttreatment-Gallium68-FAP2286-Positron-Emission-TomographyComputed-Tomography-Parameters-for-Response-and-Survival-Assessment-After-Lutetium177-FAP2286-Radioligand-Therapy-in-Advanced-Solid-Tumours

lutetium Lu 177 rofapitide tetraxetan (AAA614) - Novartis

https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub

M. Fan; Y. Chen

Sep 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next